ZNF736P8Y

Across TCGA pan-cancer cohorts, ZNF736P8Y RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated ZNF736P8Y data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher ZNF736P8Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF736P8Y expression acts as an unfavorable survival marker, although some lineages such as ESCA and MESO show a favorable association.

STAD, BRCA, and BLCA are the cancer types where ZNF736P8Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.113	0.730	<.001	93	view →
BRCA	OS	Tertile	All	0.118	0.579	<.001	60	view →
BLCA	DFS	Tertile	All	0.208	0.627	.013	45	view →
KIRP	OS	Tertile	All	0.216	0.904	<.001	45	view →
LGG	DFS	Tertile	All	0.219	0.742	<.001	42	view →
LUSC	OS	Tertile	III,IV	0.126	0.664	.008	36	view →
ESCA	DFS	Tertile	II,III,IV	1.000	0.325	.018	33	view →
SKCM	OS	Tertile	III,IV	0.301	0.707	.018	18	view →
MESO	DFS	Tertile	III,IV	0.760	0.342	.038	18	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

ZNF736P8Y–STAD (OS)

Open the STAD breakdown →